VASOACTIVE INTESTINAL PEPTIDE (VIP) IN PRETERM AND TERM NEONATES

ABSTRACT. There is a little information on vasoactive intestinal peptide (VIP) in the neonatal period. We have measured plasma concentrations of this biologically important peptide in 159 preterm infants and 98 term neonates. Preterm neonates during the first four days of life had plasma VIP concentrations which were five times greater than the levels in 12 healthy adult controls (9.6±0.7 pmol/1, mean ± S. E. M., compared with 1.95±0.5 pmol/l, p<0.001), and these elevated concentrations persisted throughout the neonatal period. In contrast term infants on the sixth day of life, had plasma VIP concentrations only half those seen in preterm infants at the same post natal age (p<0.001). Bottle‐fed term infants had higher VIP levels than those who were breast fed (5.6±0.4 vs. 4.3±0.4, p<0.05). Plasma VIP concentrations did not change following a feed in any of the groups of neonates studied. The high plasma levels of VIP described may indicate a reduced neuropepitide clearance mechanism in neonates or alternatively, suggest a hitherto unrecognised role for this peptide hormone in the neonatal period.

[1]  P. K. Lee,et al.  Watery diarrhoea with a vasoactive intestinal peptide-producing ganglioneuroblastoma. , 1980, Archives of disease in childhood.

[2]  S. Kaplan,et al.  Vasoactive intestinal peptide secreting tumors of childhood. , 1980, American journal of diseases of children.

[3]  S. Bloom,et al.  Measurement of fasting and postprandial plasma VIP in man. , 1978, Gut.

[4]  S. Bloom,et al.  Metabolic and endocrine events at the time of the first feed of human milk in preterm and term infants. , 1978 .

[5]  S. Said,et al.  Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[6]  V. Mutt,et al.  Relationship of spasmogenic and smooth muscle relaxant peptides from normal lung to other vasoactive compounds , 1977, Nature.

[7]  S. Bloom,et al.  POSSIBLE DUAL ROLE FOR VASOACTIVE INTESTINAL PEPTIDE AS GASTROINTESTINAL HORMONE AND NEUROTRANSMITTER SUBSTANCE , 1976, The Lancet.

[8]  A. M. Ebeid,et al.  The placenta as a possible source of gut peptide hormones. , 1976, Surgical forum.

[9]  P. Swift,et al.  Watery diarrhoea and ganglioneuroma with secretion of vasoactive intestinal peptide. , 1975, Archives of disease in childhood.

[10]  J. Polak,et al.  Cellular localization of a vasoactive intestinal peptide in the mammalian and avian gastrointestinal tract , 1974, Gut.

[11]  V. Mutt,et al.  Structure of the Porcine Vasoactive Intestinal Octacosapeptide , 1974 .

[12]  A. Morrison,et al.  Endocrine pancreatic islet disease with diarrhea. Report of a case due to diffuse hyperplasia of nonbeta islet tissue with a review of 54 additional cases. , 1974, Archives of internal medicine.

[13]  V. Mutt,et al.  Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination. , 1974, European journal of biochemistry.

[14]  David L Skeggs,et al.  Tumours of Childhood. , 1973 .

[15]  V. Mutt,et al.  Polypeptide with Broad Biological Activity: Isolation from Small Intestine , 1970, Science.